Daily Short Volume Trends for PLX
Protalix BioTherapeutics (PLX) has been subject to consistent short-selling pressure as evidenced by FINRA Reg SHO daily short volume data. Recent reports indicate that short volume accounted for 29.8% of total volume on September 18. While this is below the 41-day average of 43.9%, the absolute volume remains notable, with 52.5K shares shorted out of 176.1K total volume. Traders should monitor these daily flow metrics as they provide a real-time look at short-selling pressure that often precedes larger shifts in open interest.
Signal data sourced from Quantisnow. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.